Investor Relations
Corporate Profile
Axonics Modulation Technologies®, Inc., (NASDAQ: AXNX) is a global medical device company focused on the design, development, and commercialization of innovative and minimally invasive Sacral Neuromodulation solutions. Sacral Neuromodulation is a guideline-recommended therapy indicated to treat patients with overactive bladder ("OAB"), fecal incontinence ("FI"), and urinary retention ("UR").